Herbert K.

Keller, TX

Herbert Shares His COPD Cellular Therapy Story

Age: 69  |  Location: Keller, TX  |  Condition: COPD

Herbert K. has COPD and used to enjoy doing yardwork and chores. Shortness of breath and 15 percent lung capacity made him unable to do simple tasks, leaving him feeling depressed. Herbert’s wife, Barbara, had a hard time watching her husband suffer and feared that he may not live much longer. After hearing about the Lung Institute, they decided to try treatment.

Two months after his initial treatment, Herbert had a pulmonary function test, which showed his lung capacity had increased to 31 percent. His lung capacity has continued to improve after a booster treatment, and now it’s at 47 percent. Herbert and Barbara are pleased with his success.

Herbert says, “When you’re used to doing things and then they’re taken away from you, it’s hard to understand how it affects you mentally and how good it feels to do those simple things again.”

If you or someone you love has COPD, pulmonary fibrosis or another chronic lung disease and would like to see improvements like Herbert’s, contact us at 888-745-6697 to learn more about cellular therapy options.

Are you a candidate? Call 888-745-6697 to find out.

Nancy H.
Bellingham, WA
David V.
Englewood, FL
Herbert K.
Keller, TX
Don C.
Lakewood, OH
Kathleen B.
Amherst, OH
Denise F.
Smiths Creek, MI
Judy Q.
French Village, MO
Penny K.
Omaha, NE
Ronnie G.
Warren, TX
Bill B.
Wellsboro, PA
Joseph O.
Selden, NY
Rhonda S.
Macomb, MI
Tammi S.
Cleveland, OH
Becky D.
Schererville, IN
Rickie S.
Elizabeth City, NC
Brad E.
Nashville, TN
Paul B.
Chagrin Falls, OH
Lois S.
Sun City, AZ
Karl T.
Hampstead, NC
June B.
Madeira Beach, FL
Jim D.
Boca Raton, FL
Marvin S.
Lakeland, FL
Vickie B.
San Antonio, TX
Audrey S.
Fairbanks, AK
Linus S.
Hays, KS

* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.